No Data
Beacon Medical - B (02170.HK) mid-term revenue increased by 45.8% to 0.125 billion yuan.
On August 29th, Becon Medical-B (02170.HK) announced that the company's revenue increased by 45.8% to 12.47 million RMB in the six-month period ending on June 30, 2024. This increase is mainly due to (i) the inclusion of Singapore BMX's financial performance in the company's global sales performance after the acquisition of Singapore BMX; and (ii) the steady growth of sales of core products in the company's five major laboratory scenarios. The sales of PGT reagent kits, embryo culture incubators, and ultra-low temperature storage products have all achieved expected growth. The group's gross profit increased by 72.3% to June 30, 2024.
Express News | Suzhou Basecare Medical Corp - Hy Loss RMB119.9 Mln
BASECARE-B: INTERIM RESULTS ANNOUNCEMENT FOR THE SIX MONTHS ENDED JUNE 30, 2024
Becon Medical - B (02170): Jiang Junchao has been appointed as an executive director.
Quality Medical-B (02170) announced that, effective from August 29, 2024, Yang Ying has resigned as an executive director...
Express News | Suzhou Basecare Medical Corp Ltd - Yang Ying Has Resigned as an Executive Director
Medical BeiKang-B (02170.HK) will hold a board meeting on August 29 to approve the mid-term performance.
Beacon Medical -B (02170.HK) announced on August 19th that the company will hold a board of directors meeting on August 29th, 2024 to consider and approve the mid-term performance of the company and its subsidiaries for 6 months ending on June 30th, 2024, including publication, and consider issuing mid-term dividends (if any).
No Data
